NCT01594762.

Trial name or title	A randomized, double‐blind, multicenter, superiority, placebo‐controlled phase 3 study of pexiganan cream 0.8% applied twice daily for 14 days in the treatment of adults with mild infections of diabetic foot ulcers
Methods	Interventional RCT
Participants	Mild infected ulcer in diabetic patients, full‐ or partial‐thickness ulcer on the foot distal to the malleoli with a surface area ≥ 1 cm² after the wound has undergone appropriate debridement
Interventions	Pexiganan versus placebo
Outcomes	28 days clinical response, 28 days microbiological response, incidence and severity of adverse events
Starting date	2014
Contact information
Notes